ATI RN
ATI Exit Exam 2023
1. A nurse is caring for a client who has a new prescription for spironolactone. Which of the following laboratory values should the nurse monitor to evaluate the effectiveness of the medication?
- A. Serum sodium.
- B. Serum calcium.
- C. Serum potassium.
- D. Serum glucose.
Correct answer: C
Rationale: Corrected Rationale: Spironolactone is a potassium-sparing diuretic, so serum potassium should be monitored to evaluate its effectiveness. Monitoring serum potassium levels is crucial because spironolactone can cause hyperkalemia as a side effect. Serum sodium, serum calcium, and serum glucose levels are not directly affected by spironolactone and would not provide an accurate assessment of the medication's effectiveness.
2. A charge nurse is teaching a group of newly licensed nurses about the correct use of restraints. Which of the following should the nurse include in the teaching?
- A. Placing a belt restraint on a school-age child who has seizures.
- B. Securing wrist restraints to the bed rails for an adolescent.
- C. Applying elbow immobilizers to an infant receiving cleft lip injury.
- D. Keeping the side rails of a toddler's crib elevated.
Correct answer: D
Rationale: The correct answer is D. Keeping the side rails of a toddler's crib elevated is an appropriate use of restraints to prevent the child from falling, which is an essential safety measure. Placing a belt restraint on a school-age child with seizures (choice A) is not recommended as it can be dangerous during a seizure. Securing wrist restraints to the bed rails for an adolescent (choice B) may cause harm and should not be done routinely. Applying elbow immobilizers to an infant receiving a cleft lip injury (choice C) is not a standard practice for managing this condition and would not be appropriate.
3. A nurse is caring for a client who has a prescription for digoxin. Which of the following laboratory values should the nurse monitor to identify an adverse effect of this medication?
- A. Potassium 3.5 mEq/L
- B. Sodium 140 mEq/L
- C. Calcium 9.5 mg/dL
- D. Magnesium 2.0 mEq/L
Correct answer: A
Rationale: The correct answer is A: Potassium 3.5 mEq/L. Digoxin can cause hypokalemia as an adverse effect. Monitoring potassium levels is crucial because low potassium levels can increase the risk of digoxin toxicity. Choices B, C, and D are incorrect as they are not directly associated with potential adverse effects of digoxin. Sodium levels are not typically affected by digoxin, calcium levels are not a primary concern with digoxin therapy, and magnesium levels are not the most important to monitor for digoxin adverse effects.
4. What is the best initial nursing intervention for a patient with suspected pulmonary embolism?
- A. Administer oxygen
- B. Administer anticoagulants
- C. Reposition the patient
- D. Check oxygen saturation
Correct answer: A
Rationale: Administering oxygen is the best initial nursing intervention for a patient with suspected pulmonary embolism because it helps address hypoxia, a common complication of this condition. Oxygen therapy can improve oxygenation and support vital organ function. Administering anticoagulants (Choice B) is a treatment option for confirmed pulmonary embolism but not the initial intervention. Repositioning the patient (Choice C) and checking oxygen saturation (Choice D) are important assessments but do not address the immediate need to improve oxygenation in a patient with suspected pulmonary embolism.
5. A healthcare professional is reviewing laboratory results for a client who has cirrhosis. Which of the following findings should the professional report to the provider?
- A. Albumin 3.5 g/dL
- B. Bilirubin 1.0 mg/dL
- C. INR 3.0
- D. Ammonia 80 mcg/dL
Correct answer: C
Rationale: An INR of 3.0 is elevated, indicating impaired blood clotting function, which poses a significant risk of bleeding in clients with cirrhosis. This finding should be promptly reported to the provider for further evaluation and management. Choice A (Albumin 3.5 g/dL) is within the normal range and indicates adequate liver synthetic function, so it does not require immediate reporting. Choice B (Bilirubin 1.0 mg/dL) is also within the normal range and typically seen in clients without significant liver dysfunction, so it does not need urgent attention. Choice D (Ammonia 80 mcg/dL) is elevated, but it is not the priority finding in cirrhosis; elevated ammonia levels are associated with hepatic encephalopathy rather than increased bleeding risk.
Similar Questions
Access More Features
ATI RN Basic
$69.99/ 30 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access
ATI RN Premium
$149.99/ 90 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access